These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27137522)

  • 1. Anticoagulation in Pulmonary Arterial Hypertension.
    Robinson JC; Pugliese SC; Fox DL; Badesch DB
    Curr Hypertens Rep; 2016 Jun; 18(6):47. PubMed ID: 27137522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation in patients with pulmonary arterial hypertension: An update on current knowledge.
    Roldan T; Landzberg MJ; Deicicchi DJ; Atay JK; Waxman AB
    J Heart Lung Transplant; 2016 Feb; 35(2):151-64. PubMed ID: 26527532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticoagulation in pulmonary arterial hypertension].
    Grünig E; Ehlken N; Nagel Ch
    Hamostaseologie; 2008 Oct; 28(4):225-30. PubMed ID: 18836649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension?
    Khan MS; Usman MS; Siddiqi TJ; Khan SU; Murad MH; Mookadam F; Figueredo VM; Krasuski RA; Benza RL; Rich JD
    Circ Cardiovasc Qual Outcomes; 2018 Sep; 11(9):e004757. PubMed ID: 30354550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).
    Olsson KM; Delcroix M; Ghofrani HA; Tiede H; Huscher D; Speich R; Grünig E; Staehler G; Rosenkranz S; Halank M; Held M; Lange TJ; Behr J; Klose H; Claussen M; Ewert R; Opitz CF; Vizza CD; Scelsi L; Vonk-Noordegraaf A; Kaemmerer H; Gibbs JS; Coghlan G; Pepke-Zaba J; Schulz U; Gorenflo M; Pittrow D; Hoeper MM
    Circulation; 2014 Jan; 129(1):57-65. PubMed ID: 24081973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are anticoagulants still indicated in pulmonary arterial hypertension?
    Olschewski H; Rich S
    Pulm Circ; 2018; 8(4):2045894018807681. PubMed ID: 30284508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review.
    Johnson SR; Mehta S; Granton JT
    Eur Respir J; 2006 Nov; 28(5):999-1004. PubMed ID: 17074918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulation therapy in pulmonary arterial hypertension].
    Akagi S; Kusano KF
    Nihon Rinsho; 2008 Nov; 66(11):2174-8. PubMed ID: 19051739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of tissue factor and its inhibitor in chronic thromboembolic pulmonary hypertension: a step closer to explanation of the disease aetiology?
    Cisowska-Czajka ME; Mazij MP; Kotschy MH; Lewczuk J
    Kardiol Pol; 2016; 74(11):1332-1338. PubMed ID: 27221958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral anticoagulation for pulmonary arterial hypertension: systematic review and meta-analysis.
    Caldeira D; Loureiro MJ; Costa J; Pinto FJ; Ferreira JJ
    Can J Cardiol; 2014 Aug; 30(8):879-87. PubMed ID: 24986048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation and anticoagulation in pulmonary arterial hypertension.
    Berger G; Azzam ZS; Hoffman R; Yigla M
    Isr Med Assoc J; 2009 Jun; 11(6):376-9. PubMed ID: 19697592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).
    Preston IR; Roberts KE; Miller DP; Sen GP; Selej M; Benton WW; Hill NS; Farber HW
    Circulation; 2015 Dec; 132(25):2403-11. PubMed ID: 26510696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the quality of anticoagulation management in patients with pulmonary arterial hypertension.
    Roldan T; Villamañán E; Rios JJ; Waxman AB
    Thromb Res; 2017 Dec; 160():83-90. PubMed ID: 29127864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding events in pulmonary arterial hypertension.
    Opitz CF; Kirch W; Mueller EA; Pittrow D
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():68-73. PubMed ID: 19335748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic arteriopathy and anticoagulation in pulmonary hypertension.
    Johnson SR; Granton JT; Mehta S
    Chest; 2006 Aug; 130(2):545-52. PubMed ID: 16899857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation in Pulmonary Arterial Hypertension: Do We Know the Answer?
    Rawal H; Suman A; Bhoite RR; Kanwal A; Young RK; Aronow WS; Lavie C; Ghosh RK
    Curr Probl Cardiol; 2021 Mar; 46(3):100738. PubMed ID: 33250263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil.
    Ascha M; Zhou X; Rao Y; Minai OA; Tonelli AR
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28643420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary arterial hypertension: changing approaches to management].
    Sidorenko BA; Preobrazhenskiĭ DV; Batyraliev TA; Belenkov IuN
    Kardiologiia; 2011; 51(1):100-8. PubMed ID: 21626809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating pulmonary hypertension in pediatrics.
    Lador F; Sekarski N; Beghetti M
    Expert Opin Pharmacother; 2015 Apr; 16(5):711-26. PubMed ID: 25665593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.